Global Drug Manufacturing Industry Outlook to 2010: Buyer Spend and Procurement Strategies and the Impact of Recession and Recovery

Product Code GMD12643
Publication Date July 2009
Publisher Global Markets Direct
Product Type Report
Pages 111
ISBN Number not applicable
Change currency
PDF £1,265.00 €1,523 $2,000 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Global Drug Manufacturing Industry Outlook to 2010: Buyer Spend and Procurement Strategies and the Impact of Recession and Recovery

"Global Drug Manufacturing Industry Outlook to 2010" is a new report published by Global Markets Direct in association with ICD Research that analyzes how drug manufacturing companies products & services spend, procurement strategies & practices and business are being affected by the recession. In an uncertain economic climate this report gives you access to the category-level spending outlooks, buyer budgets, supplier selection criteria, business challenges and investment opportunities of leading purchase decision makers. The report also identifies buyers and suppliers future growth, M&A and investment expectations. The research is based on an extensive survey of senior and C-level industry executives from our market leading panels.

Scope

  • The opinions and forward looking statements of over 550 industry executives have been captured in our in-depth survey, of which 65% represent Directors, C-levels & Departmental Heads
  • This report covers data and analysis on buyer spend, procurement and industry developments by pharmaceutical process and manufacturing, biopharma, biotech, public sector pharma, CRO and CMO companies and leading suppliers worldwide
  • The report examines current practices and provides future expectations over the next 12-24 months
  • The research is based on primary survey research conducted by Global Markets Direct in association with ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations
  • Key topics covered include buyer spend activity, procurement behaviors & strategies and how these have been affected by the recession, threats & opportunities for the drug manufacturing industry, economic outlook and business confidence.
  • In the report buyers identify what suppliers need to do to maintain their business and the key actions being taken by industry players to overcome the leading business threats
  • The report provides qualitative analysis of the key industry threats and opportunities and contains full survey results
  • The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific and Africa & Middle East

Highlights

  • 40% of drug manufacturers expect to increase their procurement spend over the next 12 months, a further 22% looking to maintain it at current levels, however with many claiming to be re-evaluating their supplier base the market open to competition is expected to increase over the coming year
  • 38% of buyers are seeking to engage in partnerships to optimize working capital and reduce costs - closer cooperation between suppliers and buyers is being sought during this time of market uncertainty
  • Only 14% of drug manufacturers do not regularly evaluate suppliers to ensure they meet high ethical and environmental standards

Reasons to buy

  • Drive revenues by understanding future product investment areas and growth regions by leading industry players
  • Formulate effective sales & marketing strategies by identifying how buyer budgets are changing and where spend will be directed to in the future
  • Better promote your business by aligning your capabilities and business practices with your customer's changing needs during these times of market uncertainty
  • Secure stronger customer relationships by understanding the leading business concerns and changing strategies of buyers in the pharmaceutical industry
  • Effectively plan your business strategies
  • Predict how the industry will grow, consolidate and where it will stagnate
  • Uncover the business outlook, key challenges and opportunities identified by suppliers and buyers in the industry

Contents

  • 1 Table Of Contents
    • 1.1 List Of Tables
    • 1.2 List Of Figures
  • 2 Introduction
    • 2.1 What is This Report About?
    • 2.2 Methodology
    • 2.3 Profile Of Survey Respondents
  • 3 Executive Summary
  • 4 Economic Outlook & Confidence
    • 4.1 Global Economy Recovery Expectations
    • 4.2 Revenue Growth Expectations
  • 5 Drug Manufacturing Industry Investment Outlook
    • 5.1 Fastest & Slowest Growing Markets
    • 5.2 M&A Activity Predictions
    • 5.3 Supplier's Industry Outlook
  • 6 Recession: Threats & Opportunities For The Drug Manufacturing Industry
    • 6.1 Leading Business Concerns Due To Recession
    • 6.2 Key Actions To Overcome Business Threats
    • 6.3 Key Actions To Maintain & Win Buyer Business
    • 6.4 Leading Recession-Related Business Opportunities
  • 7 Drug Manufacturing Industry Buyer Spend Activity
    • 7.1 Annual Procurement Budgets
    • 7.2 Expected Change In Procurement Spend
    • 7.3 Expected Change In Spend By Product & Service Category
  • 8 Procurement Behaviors & Strategies & The Impact Of Recession
    • 8.1 Critical Success Factors For Supplier Selection
    • 8.2 Current Effects Of Recession On Procurement Objectives
    • 8.3 Expected Future Effects Of Recession On Procurement Objectives
    • 8.4 The Effects Of Recession On Procurement Strategy
  • 9 Appendix
    • 9.1 Full Survey Results
    • 9.2 Methodology
    • 9.3 Contact Us
    • 9.4 About Global Markets Direct
    • 9.5 Disclaimer
    • 1.1 List Of Tables
    • Table 1: Count Of Global Drug Manufacturing Industry Survey Respondents By Company Type (Number Of Respondents), 2009 Industry Survey
    • Table 2: Buyer Respondents By Job Role (% Buyer Respondents), Global Drug Manufacturing Industry, 2009
    • Table 3: Buyer Respondents By Organization's Global Turnover (% Buyer Respondents), Global Drug Manufacturing Industry, 2009
    • Table 4: Buyer Respondents By Organization's Total Employee Size (% Buyer Respondents), Global Drug Manufacturing Industry, 2009
    • Table 5: Supplier Respondents By Job Role (% Supplier Respondents), Global Drug Manufacturing Industry, 2009
    • Table 6: Supplier Respondents By Organization's Global Turnover (% Supplier Respondents), Global Drug Manufacturing Industry, 2009
    • Table 7: Supplier Respondents By Organization's Total Employee Size (% Supplier Respondents), Global Drug Manufacturing Industry, 2009
    • Table 8: Global Drug Manufacturing Industry Expectations Of Global Economy Recovery Timings By Region: North America, Europe, Asia-Pacific, Rest Of World (% All Respondents), 2009
    • Table 9: Global Drug Manufacturing Industry Expectations Of Global Economy Recovery Timings By Company Type: Drug Manufacturers, Contract Research Organizations / Contract Manufacturing Organizations, Drug Manufacturing Industry Suppliers (% All Respondents), 2009
    • Table 10: Company Revenue Growth Optimism By Global Drug Manufacturing Industry Company Type: Drug Manufacturers, Contract Research Organizations / Contract Manufacturing Organizations, Drug Manufacturing Industry Suppliers (% All Respondents), 2009
    • Table 11: Company Revenue Growth Optimism In The Global Drug Manufacturing Industry By Region: North America, Europe, Asia-Pacific, Rest Of World (% All Respondents), 2009
    • Table 12: Drug Manufacturer Industry: Market Predictions Of The Fastest And Slowest Growing Regions (% Drug Manufacturer Respondents), 2009
    • Table 13: Drug Manufacturing Industry Supplier Industry: Market Predictions Of The Fastest And Slowest Growing Regions (% Drug Manufacturing Industry Supplier Respondents), 2009
    • Table 14: Drug Manufacturing Industry Supplier Industry: Market Predictions Of The Fastest And Slowest Growing Regions (% Drug Manufacturing Industry Supplier Respondents), 2009
    • Table 15: Key Growth Areas In The Drug Manufacturing Industry (Analysis Of Supplier Respondents), 2009 Industry Survey
    • Table 16: Key Growth Areas In The Drug Manufacturing Industry ??